Israel Englander Ionis Pharmaceuticals Inc Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Millennium Management LLC holds 430,723 shares of IONS stock, worth $15.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

430,723

Previous 128,215 235.94%

Holding current value

$15.5 Million

Previous $6.11 Million 182.39%

% of portfolio

0.01%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.06 - $51.86 $12.1 Million - $15.7 Million	302,508 Added 235.94%	430,723 $17.3 Million
Q2 2024 Aug 14, 2024	SELL	$36.45 - $47.7 $16.6 Million - $21.7 Million	-454,964 Reduced 78.01%	128,215 $6.11 Million
Q1 2024 May 15, 2024	SELL	$42.03 - $53.55 $12.9 Million - $16.4 Million	-307,146 Reduced 34.5%	583,179 $25.3 Million
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $20.5 Million - $24.3 Million	471,412 Added 112.53%	890,325 $45 Million
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $13 Million - $16.2 Million	373,550 Added 823.47%	418,913 $17.2 Million
Q1 2023 May 15, 2023	SELL	$33.58 - $41.2 $2.36 Million - $2.89 Million	-70,143 Reduced 60.73%	45,363 $1.62 Million
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $3.58 Million - $4.49 Million	96,577 Added 510.21%	115,506 $4.36 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $11 Million - $14.7 Million	-301,686 Reduced 94.1%	18,929 $837,000
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $4.1 Million - $5.57 Million	129,424 Added 67.69%	320,615 $11.9 Million
Q1 2022 May 16, 2022	SELL	$29.88 - $37.04 $42.8 Million - $53 Million	-1,431,947 Reduced 88.22%	191,191 $7.08 Million
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $34.3 Million - $47 Million	1,340,284 Added 473.84%	1,623,138 $49.4 Million
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $17.2 Million - $20.8 Million	-512,988 Reduced 64.46%	282,854 $9.49 Million
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $5.68 Million - $7.78 Million	164,578 Added 26.07%	795,842 $31.7 Million
Q1 2021 May 17, 2021	BUY	$42.51 - $63.78 $4.28 Million - $6.42 Million	100,675 Added 18.97%	631,264 $28.4 Million
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $19.1 Million - $25.4 Million	421,632 Added 386.97%	530,589 $30 Million
Q3 2020 Nov 16, 2020	BUY	$47.45 - $62.95 $4.54 Million - $6.02 Million	95,588 Added 715.0%	108,957 $5.17 Million
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $2.73 Million - $3.55 Million	-58,223 Reduced 81.33%	13,369 $788,000
Q1 2020 May 14, 2020	BUY	$41.6 - $63.4 $2.56 Million - $3.9 Million	61,528 Added 611.37%	71,592 $3.39 Million
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $2.43 Million - $2.95 Million	-45,141 Reduced 81.77%	10,064 $608,000
Q3 2019 Nov 14, 2019	SELL	$59.06 - $72.15 $8.02 Million - $9.79 Million	-135,739 Reduced 71.09%	55,205 $3.31 Million
Q2 2019 Aug 15, 2019	BUY	$62.09 - $86.14 $9.99 Million - $13.9 Million	160,970 Added 537.03%	190,944 $12.3 Million
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $8.39 Million - $11.6 Million	-135,065 Reduced 81.84%	29,974 $544,000
Q1 2019 May 14, 2019	BUY	$52.92 - $81.17 $4.32 Million - $6.62 Million	81,561 Added 97.7%	165,039 $13.4 Million
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $1.95 Million - $2.67 Million	-44,849 Reduced 34.95%	83,478 $4.51 Million
Q3 2018 Nov 14, 2018	SELL	$42.88 - $53.7 $2.3 Million - $2.88 Million	-53,607 Reduced 29.47%	128,327 $6.62 Million
Q2 2018 Aug 14, 2018	SELL	$40.53 - $50.7 $3.68 Million - $4.61 Million	-90,903 Reduced 33.32%	181,934 $7.58 Million
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $3.39 Million - $4.23 Million	76,920 Added 39.26%	272,837 $12 Million
Q4 2017 Feb 14, 2018	BUY	$50.3 - $64.39 $144,562 - $185,056	2,874 Added 1.49%	195,917 $9.86 Million
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $8.8 Million - $11.5 Million	193,043	193,043 $9.79 Million

Others Institutions Holding IONS

# of Institutions

404

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.1B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account